PCI Right After CABG: How Bad Can it Be?

In-hospital PCI right after CABG is extremely rare, but it does increase morbidity, mortality and costs significantly.

It is still unclear what predictors can be modified to prevent these very early angiography and angioplasty procedures in patients that generally leave the OR with visible EKG changes. Graft failure, distal vascular bed quality, technical error or maybe simply spasm caused by manipulation.

 

Fortunately, every once and again, we are presented with recovering patients with ST elevation right out of surgery and there is no alternative but to take them to the cath lab.


Read also: TAVR Learning Curve and Volume-Outcomes Relationship Plateau.


In general, when ST elevation is in the inferior leads (DII, DIII, aVF) we find patent grafts that, most probably, stem from a badly purged system and a resulting air embolism.

 

Quite different are the cases when ST elevation is anterior; here in general, we see problems such as occluded mammary arteries, spasmed anterior descending arteries and a bad vascular bed, etc. Nitroglycerin should be the first course of action, seeing as PCI on such recent anastomosis involves a high risk of rupture.

 

This study included 554987 patients, 24503 (4.4%) were suspected of having acute ischemia and received an angiography after surgery. Other 14323 also required PCI.


Read also: EXCEL Outcomes: PCI vs CABG in Patients with Prior Cerebrovascular disease.


In the PCI group, mortality was two times higher than in patients with no signs of post CABG ischemia (5.1% vs. 2.7%; p<0.001). The problem was seen not only in increased mortality, but also in increased stroke (2.1% vs. 1.6%; p<0.001), increased acute kidney failure (16% vs. 12.3%; p<0.001) and infection complications.

 

It also increased hospital stay, and in turn increased costs by 50%.

 

Non-elective and off-pump surgery were predictors of post CABG PCI.

 

Conclusion

Immediate post CABG PCI is quite uncommon, but it significantly increased morbidity, mortality and costs. Further studies should focus on the way to reduce modifiable risk factors to prevent these events from happening.

 

Original title: Incidence, Predictors, and Outcomes of In-Hospital Percutaneous Coronary Intervention Following Coronary Artery Bypass Grafting.

Reference: Fahad Alqahtani et al. J Am Coll Cardiol 2019;73:415–23.


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

We are interested in your opinion. Please, leave your comments, thoughts, questions, etc., below. They will be most welcome.

More articles by this author

Coronary Artery Disease in Aortic Stenosis: CABG + SAVR vs. TAVR + PCI: Data from Spanish Centers

Multiple randomized studies have shown comparable or superior efficacy of transcatheter aortic valve replacement (TAVR) vs. coronary artery bypass graft (CABG).  However, many of...

Evolution of Small Balloon-Expandable Valves

Small aortic rings (20 mm) have posed a significant challenge for both surgery and transcatheter aortic valve implantation (TAVI) due to their association with an...

TCT 2024 | FAVOR III EUROPA

The study FAVOR III EUROPA, a randomized trial, included 2,000 patients with chronic coronary syndrome, or stabilized acute coronary syndrome, and intermediate lesions. 1,008...

TCT 2024 – ECLIPSE: Randomized Study of Orbital Atherectomy vs Conventional PCI in Severely Calcified Lesions

Coronary calcification is associated with stent under-expansion and increased risk of both early and late adverse events. Atherectomy is an essential tool for uncrossable...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

Severe Tricuspid Regurgitation: Surgical vs. Transcatheter Edge-to-Edge Repair

While highly prevalent, tricuspid regurgitation is a notably undertreated valvulopathy. Its progression has been associated with higher mortality and significant disability. According to the...

ACCESS-TAVI: Comparing Post TAVR Vascular Closure Devices

Transcatheter aortic valve replacement (TAVR) is a well-established option to treat elderly patients with severe symptomatic aortic valve stenosis. Technical advances and device development...

Endovascular Treatment of Iliofemoral Disease for the Improvement of Heart Failure with Preserved Ejection Fraction

Peripheral artery disease (PAD) is a significant risk factor in the development of difficult-to-treat conditions, such as heart failure with preserved ejection fraction (HFpEF)....